Case of relentless chronic phase of chronic myeloid leukaemia

Onyee Chan, Hao Chen, Ravitharan Krishnadasan, Faiz Anwer

Research output: Contribution to journalArticle


Initial treatment of chronic phase chronic myeloid leukaemia is straightforward in today's era of tyrosine kinase inhibitors. However, managing refractory cases remain a major challenge due to the multiple factors that can influence decision-making, including medication tolerance, disease burden, mutation status, comorbidities, availability of donor, and fitness for an ablative conditioning. We report a male patient presenting with chronic phase chronic myeloid leukaemia who was treated with 5 different tyrosine kinase inhibitors either due to intolerance and/or failed response. He subsequently received 2 haploidentical haematopoietic stem cells transplants before achieving complete remission. This case highlights various treatment options, need for vigilant disease monitoring, and the possibility of complete positive response even after many lines of therapy failure.

Original languageEnglish (US)
Article number215370
JournalBMJ Case Reports
Publication statusPublished - Jan 1 2016
Externally publishedYes


ASJC Scopus subject areas

  • Medicine(all)

Cite this